169 related articles for article (PubMed ID: 28922069)
1. Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the Literature.
Mechler K; Häge A; Schweinfurth N; Glennon JC; Dijkhuizen RM; Murphy D; Durston S; Williams S; K Buitelaar J; Banaschewski T; Dittmann RW; Tactics Consortium T
Z Kinder Jugendpsychiatr Psychother; 2018 May; 46(3):246-263. PubMed ID: 28922069
[TBL] [Abstract][Full Text] [Related]
2. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
[TBL] [Abstract][Full Text] [Related]
3. Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies.
Naaijen J; Lythgoe DJ; Amiri H; Buitelaar JK; Glennon JC
Neurosci Biobehav Rev; 2015 May; 52():74-88. PubMed ID: 25712432
[TBL] [Abstract][Full Text] [Related]
4. Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications.
Vlček P; Polák J; Brunovský M; Horáček J
Pharmacopsychiatry; 2018 Nov; 51(6):229-242. PubMed ID: 28950396
[TBL] [Abstract][Full Text] [Related]
5. Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder.
Naaijen J; Zwiers MP; Amiri H; Williams SCR; Durston S; Oranje B; Brandeis D; Boecker-Schlier R; Ruf M; Wolf I; Banaschewski T; Glennon JC; Franke B; Buitelaar JK; Lythgoe DJ
Neuropsychopharmacology; 2017 Nov; 42(12):2456-2465. PubMed ID: 27869141
[TBL] [Abstract][Full Text] [Related]
6. Obsessive compulsive disorder and the glutamatergic system.
Kariuki-Nyuthe C; Gomez-Mancilla B; Stein DJ
Curr Opin Psychiatry; 2014 Jan; 27(1):32-7. PubMed ID: 24270485
[TBL] [Abstract][Full Text] [Related]
7. Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.
Marinova Z; Chuang DM; Fineberg N
Curr Neuropharmacol; 2017; 15(7):977-995. PubMed ID: 28322166
[TBL] [Abstract][Full Text] [Related]
8. What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review.
Smith L; Tracy DK; Giaroli G
J Clin Psychopharmacol; 2016 Feb; 36(1):57-62. PubMed ID: 26629962
[TBL] [Abstract][Full Text] [Related]
9. COMPULS: design of a multicenter phenotypic, cognitive, genetic, and magnetic resonance imaging study in children with compulsive syndromes.
Naaijen J; de Ruiter S; Zwiers MP; Glennon JC; Durston S; Lythgoe DJ; Williams SC; Banaschewski T; Brandeis D; Franke B; Buitelaar JK
BMC Psychiatry; 2016 Oct; 16(1):361. PubMed ID: 27782808
[TBL] [Abstract][Full Text] [Related]
10. Striatal structure and its association with N-Acetylaspartate and glutamate in autism spectrum disorder and obsessive compulsive disorder.
Naaijen J; Zwiers MP; Forde NJ; Williams SC; Durston S; Brandeis D; Glennon JC; The Tactics Consortium ; Franke B; Lythgoe DJ; Buitelaar JK
Eur Neuropsychopharmacol; 2018 Jan; 28(1):118-129. PubMed ID: 29169826
[TBL] [Abstract][Full Text] [Related]
11. Developmental changes in fronto-striatal glutamate and their association with functioning during inhibitory control in autism spectrum disorder and obsessive compulsive disorder.
Hollestein V; Buitelaar JK; Brandeis D; Banaschewski T; Kaiser A; Hohmann S; Oranje B; Gooskens B; Durston S; Williams SCR; Lythgoe DJ; Naaijen J
Neuroimage Clin; 2021; 30():102622. PubMed ID: 33765540
[TBL] [Abstract][Full Text] [Related]
12. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature.
Spencer AE; Uchida M; Kenworthy T; Keary CJ; Biederman J
J Clin Psychiatry; 2014 Nov; 75(11):1226-41. PubMed ID: 25271988
[TBL] [Abstract][Full Text] [Related]
14. Shared or Distinct Alterations in Brain Structure in Disorders Across the Impulsivity-Compulsivity Spectrum: What Can We Learn From Cross-Disorder Comparisons of ADHD, ASD, and OCD?
Fairchild G
Am J Psychiatry; 2020 Sep; 177(9):799-801. PubMed ID: 32867517
[No Abstract] [Full Text] [Related]
15. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.
Grant JE; Odlaug BL; Kim SW
Arch Gen Psychiatry; 2009 Jul; 66(7):756-63. PubMed ID: 19581567
[TBL] [Abstract][Full Text] [Related]
16. Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.
Bernhardt EB; Walsh KH; Posey DJ; McDougle CJ
J Clin Psychopharmacol; 2011 Oct; 31(5):673-5. PubMed ID: 21881459
[No Abstract] [Full Text] [Related]
17. Treating impulsivity with probiotics in adults (PROBIA): study protocol of a multicenter, double-blind, randomized, placebo-controlled trial.
Arteaga-Henríquez G; Rosales-Ortiz SK; Arias-Vásquez A; Bitter I; Ginsberg Y; Ibañez-Jimenez P; Kilencz T; Lavebratt C; Matura S; Reif A; Rethelyi J; Richarte V; Rommelse N; Siegl A; Ramos-Quiroga JA
Trials; 2020 Feb; 21(1):161. PubMed ID: 32046750
[TBL] [Abstract][Full Text] [Related]
18. Transdiagnostic variations in impulsivity and compulsivity in obsessive-compulsive disorder and gambling disorder correlate with effective connectivity in cortical-striatal-thalamic-cortical circuits.
Parkes L; Tiego J; Aquino K; Braganza L; Chamberlain SR; Fontenelle LF; Harrison BJ; Lorenzetti V; Paton B; Razi A; Fornito A; Yücel M
Neuroimage; 2019 Nov; 202():116070. PubMed ID: 31382045
[TBL] [Abstract][Full Text] [Related]
19. Unpacking the role of self-reported compulsivity and impulsivity in obsessive-compulsive disorder.
Prochazkova L; Parkes L; Dawson A; Youssef G; Ferreira GM; Lorenzetti V; Segrave RA; Fontenelle LF; Yücel M
CNS Spectr; 2018 Feb; 23(1):51-58. PubMed ID: 28487007
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis.
de Boer JN; Vingerhoets C; Hirdes M; McAlonan GM; Amelsvoort TV; Zinkstok JR
Psychiatry Res; 2019 Aug; 278():294-302. PubMed ID: 31254879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
